SHORT TERM TRADEChart - downtrend
For short term trade only:
Possible entry : RM1.31 - RM1.37
TP : RM1.50 (If breaks beyond RM1.50 with high volume, it means break of structure
SL: RM1.26
#TAYOR
Duopharma Biotech Bhd.
No trades
No trades
Compare with Duopharma Biotech Bhd.
0.11 MYR
87.46 M MYR
931.69 M MYR
425.42 M
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Company info
Sector
Industry
CEO
Wan Amir Jeffery bin Wan Abdul Majid
Website
Headquarters
Klang
Founded
2000
IPO date
Jun 18, 2002
ISIN
MYL7148OO009
FIGI
BBG000N9YML5
Identifiers
ISIN MYL7148OO009
Duopharma Biotech Bhd. is an investment holding company, which engages in the manufacturing and distribution of pharmaceutical products. The firm offers consumer healthcare, classic pharmaceutical, and specialty pharmaceutical products. It operates through the Local and Export geographical segments. The company was founded in 2000 and is headquartered in Klang, Malaysia.
DPHARMA: READY TO GO?Chart: Uptrend on weekly timeframe
Price is in the phase of accumulation
SL: within swap zone area
#trade at your own risk
break up and take action to long.first set the cut lost point before enter. I think the first resistant at 1.29 will break easily and going back to it fundamental value around 1.30-1.40.
Long
Ascending Triangle Pattern @ DPHARMA1. Ascending triangle pattern can be seen
2. Price always bounce at the pattern support.
3. No abnormalities can be seen in volume, RSI and OBV.
4. Potential RR ratio is 2.5:1
DPHARMAEP 1.39/1.43
TP 1.54
SL 1.33
Backtest result from 2022-07-27 10:30:00
46 trades
83% win rate
p.s: not a financial advice
#deepagiscreener #tayor #bursa #bukanbuycall
Long
DPHARMA: POISED TO CLIMB TOWARDS TP1
Price Breakout downtrendline leaving fresh demand area 1.32-1.37.
TP1 area 1.48-1.52 confluence bearish engulfing zone
Lets monitor closely!
*Personal opinion trade at your own risk*
DPHARMA: Very high potential to test near resistant levelTechnically Dpharma is on an uptrend mode. Possible test near resistance in the near term.
TAYOR!
Long
<TradeVSA> Failed Shakeout with Weakness in Dpharma & PharmaSign of Weakness in the Chart:
1. Buying Climax with Up-Thrust
2. Potential Distribution
3. Failed Shakeout
Disclaimer
This information only serves as reference information and does not constitute a buy or sell call. Conduct your own research and assessment before deciding to buy or sell any stock
Long
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
The current price of DPHARMA is 1.25 MYR — it has decreased by −0.79% in the past 24 hours. Watch Duopharma Biotech Bhd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MYX exchange Duopharma Biotech Bhd. stocks are traded under the ticker DPHARMA.
DPHARMA stock has risen by 2.46% compared to the previous week, the month change is a 2.46% rise, over the last year Duopharma Biotech Bhd. has showed a −3.10% decrease.
We've gathered analysts' opinions on Duopharma Biotech Bhd. future price: according to them, DPHARMA price has a max estimate of 1.79 MYR and a min estimate of 1.57 MYR. Watch DPHARMA chart and read a more detailed Duopharma Biotech Bhd. stock forecast: see what analysts think of Duopharma Biotech Bhd. and suggest that you do with its stocks.
DPHARMA reached its all-time high on Nov 10, 2020 with the price of 3.29 MYR, and its all-time low was 0.19 MYR and was reached on Nov 27, 2003. View more price dynamics on DPHARMA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
DPHARMA stock is 2.40% volatile and has beta coefficient of 0.60. Track Duopharma Biotech Bhd. stock price on the chart and check out the list of the most volatile stocks — is Duopharma Biotech Bhd. there?
Yes, you can track Duopharma Biotech Bhd. financials in yearly and quarterly reports right on TradingView.
Duopharma Biotech Bhd. is going to release the next earnings report on Nov 12, 2026. Keep track of upcoming events with our Earnings Calendar.
DPHARMA net income for the last quarter is 29.87 M MYR, while the quarter before that showed 30.71 M MYR of net income which accounts for 0.00% change. Track more Duopharma Biotech Bhd. financial stats to get the full picture.
Yes, DPHARMA dividends are paid semi-annually. The last dividend per share was 0.03 MYR. As of today, Dividend Yield (TTM)% is 3.61%. Tracking Duopharma Biotech Bhd. dividends might help you take more informed decisions.
Duopharma Biotech Bhd. dividend yield was 3.64% in 2025, and payout ratio reached 50.06%. The year before the numbers were 2.40% and 46.08% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Aug 19, 2026, the company has 2 K employees. See our rating of the largest employees — is Duopharma Biotech Bhd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Duopharma Biotech Bhd. EBITDA is 209.05 M MYR, and current EBITDA margin is 20.61%. See more stats in Duopharma Biotech Bhd. financial statements.
Like other stocks, DPHARMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Duopharma Biotech Bhd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Duopharma Biotech Bhd. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Duopharma Biotech Bhd. stock shows the sell signal. See more of Duopharma Biotech Bhd. technicals for a more comprehensive analysis.